Expression of osteopontin, a urinary inhibitor of stone mineral crystal growth, in rat kidney. Cultured mouse kidney cortical cells secrete osteopontin, a bone matrix protein that is also found in urine. Osteopontin is associated with cell proliferation/tumerogenesis and also inhibits kidney stone mineral crystal growth [1}. Using antibodies raised against osteopontin isolated from the culture medium, we localized osteopontin in normal rat kidney. Fluorescence, confocal and electron microscopy revealed osteopontin primarily in cells of the descending thin limb of the loop of Henle (DTL) and in papillary surface epithelium (PSE) in the area of the calyceal fornix. In situ hybridization with labeled RNA made from a eDNA that contains the entire coding sequence for mouse osteopontin revealed message at the same sites at which protein was demonstrated by immunocytochemistry. Immunogold labeling was localized to a population of dense vesicles distinct from lysosomes and endosomes. To examine the turnover of osteopontin, rats were injected with the protein synthesis inhibitor cyclohexamide, 14 mg/kg, six hours prior to kidney fixation.
Urine contains inhibitors of stone mineral crystal growth [21. These may be responsible, in part, for the relative infrequency of nephrolithiasis and urolithiasis despite supersaturation of tubular fluid and urine in the chemical constituents of calcium-containing urinary calculi. Most of the inhibitory activity of urine is due to proteins [3, 41. Two proteinaceous inhibitors of calcium oxalate crystal growth have so far been identified [2] . Nephrocalcin is an acidic glycoprotein containing the somewhat unusual residue y-carboxyglutamic acid. This protein has not been completely characterized. Worcester et al recently reported the isolation of a second stone mineral crystal growth inhibitory protein from the medium of primary cultures of mouse kidney cortex cells [1] . Since the first 21 amino acids of this isolate match the N-terminus of the bone phosphoprotein, osteopontin, and, in addition, antibodies raised to fusion proteins containing N-or C-terminal portions of os-osteopontin, has been isolated from human urine [5] . Thus, it seems likely that osteopontin or related proteins are part of the normal defense against formation of urinary calculi. Furthermore, it is possible that abnormalities in the secretion or processing of osteopontin may play a role in the pathophysiology of nephrolithiasis.
In the present study, we have examined the immunocytochemical expression of osteopontin in normal rat kidney using an antibody raised against the protein isolated from mouse cortical cell culture medium. Examination by conventional fluorescence, as well as confocal and electron microscopy of sections cut by a number of techniques has identified osteopontin primarily in cells of the descending thin limb of the loop of Henle (DTL) and in papillary surface epithelium (PSE) in the area of the calyceal fornix. The immunocytochemical signal has been localized to a population of presumed secretory vesicles distinct from lysosomes and endosomes. Thus, this urinary inhibitor of crystal growth may be secreted at sites proximate to that of the greatest degree of supersaturation of the components of calcium-containing kidney stones.
Methods
Isolation of osteopontin from mouse cortical cell culture medium, characterization of its calcium oxalate crystal inhibitory activity and generation in rabbits of a polyclonal antiserum against the protein has previously been described [1] . Affinity purification of the antiserum was accomplished by incubation with nitrocellulose strips to which purified osteopontin run on 10% SDSpolyacrylamide gels was blotted [6] . Antibody was bound in 50 mM Tris-HCI (pH 7.2), 150 mM NaCl, 0.5% Tween-20, containing 0.25% gelatin, at a dilution of 1:50, overnight. Strips were washed with this solution several times and antibody eluted in 100 mi glycine-HC1, pH 2.5, 150 mrvt NaCl for five minutes, which was then neutralized with 1 M Tris-HC1, pH 8. IgG content was determined in a sandwich ELISA, using purified rabbit IgG Rats were anesthetized with sodium pentobarbital. Bladder urine was collected, and the following protease inhibitors were added from concentrated stocks to the indicated final concentrations: 1 M leupeptin, 200 iM PMSF, 1 M pepstatin and 100 ILM EDTA. The urine from several rats was pooled and frozen at -80°C until analysis. ELISA was performed as previously described [1] .
Rat kidneys for peroxidase immunocytochemistiy were removed and fixed in formalin, paraffin-embedded, and 5 tm sections cut. Sections were dewaxed by incubation in xylene followed by incubations in progressively decreasing concentrations of ethanol, and finally in water. Endogenous peroxidase was blocked by incubation with 0.3% H202 in methanol for 20 minutes. Slides were blocked with 2% bovine serum albumin in PBS, pH 7.2, containing 15 pi/ml nonimmune goat serum for one hour, then incubated with either anti-osteopontin or non-immune serum at a dilution of 1:1000 in the same buffer (without goat Kidneys were fixed for immunocytochemistry of frozen or plastic embedded sections by perfusion with a paraformaldehydeperiodate-lysine fixative as previously described [7] . Some animals were injected intravenously 20 minutes prior to fixation with a solution of 3.125 mg/ml fixable FITC-Dextran (Molecular Probes, Eugene, OR, USA) in Hank's buffer [7] . Tissue was infiltrated in 30% sucrose overnight and 5 m sections were cut and mounted on Superfrost/Plus microscope slides (Fisher Scientific, Pittsburgh, PA, USA). Tissue was also infiltrated with 2.3 M sucrose overnight, cut into ultrathin (60 nm) sections and mounted on carbon/Parlodion-coated, nickel grids. In addition, some of the tissue was cut into 1 mm cubes and dehydrated through a series of graded ethanols and embedded in Epon. Indirect immunocytochemistry was performed on thin frozen sections using fluorescein or rhodamine conjugated secondary antibodies as previously described [8] . Indirect immunofluorescence on semithin Eponembedded tissue was performed in a similar manner after Epon removal with a solution containing 2 g KOH in 10 ml methanol and 5 ml propylene oxide [9] . Incubation of ultrathin frozen sections with primary and secondary antibodies, 8 nm protein A-gold conjugates and counterstaining was performed as previously described [8] . Except where specifically indicated, sections were incubated with the unpurified osteopontin antiserum. Dilutions of either 1:500 or 1:250 were used. The LGP 120 antiserum was used at a dilution of 1:100. When sections were incubated in affinity-purified osteopontin antiserum, it was used undiluted. Thin and semi-thin sections were examined and photographed using a Nikon FXA microscope equipped for epifluorescence. Kodak Tmax-400 film was used at a setting of 1600 ASA. Some sections were also examined using the Biorad MRC600 confocal microscope. Ultrastructural examination was performed using a Phillips CM1O electron microscope.
A probe for in situ hybridization was prepared from a cDNA for osteopontin (2ar) supplied by D. T. Denhardt (Rutgers University, Piscataway, NJ, USA). The plasmid was linearized with Eco Ri and PST1, and transcription was accomplished in the presence of [35S]-UTP with T7 and SP6 RNA polymerases respectively to generate single-stranded sense and anti-sense RNA probes.
Five micrometer cryosections of PLP-fIxed rat kidney were incubated with the probes as previously described by Kanai et al [10] . Comparison of the protein encoded by 2ar with rat osteopontin was performed using a software package (Genetics Computer Group, Madison, WI, USA).
Results
Identifi cation of osteopontin in rat urine by ELISA Using a competitive ELISA with antiserum raised against the mouse cortical cell culture 80 kDa protein, the concentration of osteopontin in pooled rat urine was determined to be 6.4 gIml. This antibody recognizes a band of appropriate Mr in Western blots of rat urinary protein (data not shown).
Segmental cytochemical identification of osteopontin
By indirect immunoperoxidase staining, osteopontin was found in two areas of the kidney: along the renal pelvis and in the inner stripe of the outer medulla (Fig. 1) . Staining was most intense in the calyceal fornix and tapered off both over the papillary surface towards the tip and over the lateral surface of the calyx. Immunofluorescence on 5 tm frozen sections also showed osteopontin in tubule cells of the DTL (Fig. 2a) . Counterstaining with Evans' Blue clearly indicated that the osteopontin immunofluorescence was localized in segments contiguous with tubules possessing a luxuriant brush border, that is, S3 portions of proximal tubules. Double staining with an antibody against Tamm-Horsfall glycoprotein as well as the osteopontin antiserum never gave colocalization (data not shown). Osteopontin was also detected in an occasional distal tubule or connecting duct segment (Fig. 2b) , identified by its proximity to the glomerulus, lack of brush border and the presence of a minority population of cells protruding into the tubular lumen, presumably intercalated cells. The preimmune serum gave virtually no immunostaining anywhere in the kidney.
Subcellular localization of osteopontin
Indirect immunofluorescence of semi-thin sections suggested that osteopontin resides mainly within a population of intracellular vesicles. Both in the DTL (Fig. 3a) and in the PSE (Fig. 3b) , these large vesicles were mainly localized to the apical region of cells. This was confirmed by immunocytochemistry of ultrathin frozen sections. Figure 4 shows immunogold localization of osteopontin on an ultrathin frozen section of PSE. Gold particles were concentrated in some electron-dense vesicles. 
Categorization of vesicles containing osteopontin
To determine whether the osteopontin staining observed in these cells is due to uptake from tubular fluid or urine of protein made elsewhere, two protocols were used to distinguish these osteopontin-containing vesicles from endocytotic vesicles and lysosomes. Tissue from FITC-Dextran injected animals was incubated with the osteopontin antiserum and stained with rhodamine-conjugated secondary antibody. There was little if any uptake of FITC-Dextran in descending limb cells and, thus, no colocalization of osteopontin was observed (data not shown). In the papillary surface, FITC-Dextran uptake into endosomic vesides was observed in some cells; however, the pattern of osteopontin localization was clearly quite different. Specifically, FITCDextran uptake was observed in areas where there was no or little immunostaining for osteopontin (Fig. 5 a, b) , and, conversely, no FITC-Dextran uptake was observed in other areas where osteopontin was detectable (Fig. 5 c, d ).
To distinguish osteopontin-containing vesicles from lysosomes, tissue sections were incubated with an antiserum against the lysosomal glycoprotein LGP 120 as well as the osteopontin antiserum. The pattern observed with indirect immunofluorescence was clearly different.
LGP 120 staining was abundant in S3 proximal tubule segments, mainly in a vesicular pattern in a subapical and perinuclear distribution (Fig. 6a) . Comparing the image of the LGP 120 staining with the image showing the tissue counterstaining (Fig. 6b ) reveals little if any vesicular LGP 120 staining in the contiguous descending limb (Fig. 6b) . Osteopontin staining, however, was widespread in DTL cells, particularly concentrated in large vesicles at or near the apical membrane (Fig. 3a) . PSE had a greater amount of LGP 120 immunostaining than descending limbs. There were some small positive subapical vesicles, but most of the LGP 120 in this tissue was observed in large vesicles around the nucleus (Fig. 6c) , especially numerous toward the basal portion of the cells, as we have previously reported [7] . Indirect immunofluorescence with osteopontin antiserum, however, detected vesicles that were mostly in an apical or subapical location (Fig. 6d) . In connecting segment or collecting duct, the pattern of LGP 120 distribution was not so clearly different from that of osteopontin (compare Fig. 6e with 2b) .
Together with the results of in situ hybridization (vide infra), these results suggest that osteopontin made and secreted by thin limb cells may be taken up from the tubular fluid at more distal sites in the nephron, accounting for some or all of the immunostaining occasionally observed there. Localization of osteopontin mRNA osteopontin was localized by immunocytochemistry. No specific To determine if the sites of osteopontin localization by immu-message was detected in other tubule segments. In contrast, the nocytochemistry represent sites of production, osteopontin sense probe showed non-specific hybridization throughout the mRNA was localized using in situ hybridization. The sense and sections (data not shown). anti-sense probes were made from 2ar, a cDNA containing the Turnover of osteopontin coding region for a murine homolog of rat osteopontin, a 44 kD As a first step in determining if osteopontin production is bone phosphoprotein. The 21 N-terminal amino acids of the physiologically regulated, turnover of the protein was assessed.
protein against which the antiserum used in the current study was Immunocytochemical localization of osteopontin was performed raised were identical in sequence to that predicted for 2ar [1] . The in tissue sections after protein synthesis was inhibited. Kidney anti-sense probe demonstrated silver grains thin segments contig-sections fixed six hours after injecting animals with cyclohexamide, uous with thick tubules (Fig. 7a) . Despite the inability to identify 14 mg/kg body weight, showed complete loss of staining in the brush borders in these thick tubule profiles, since silver grains DTL and attenuation of immunofluorescence in the PSE (Fig. 8) .
were never observed at the beginning of the inner medulla, the thin tubules so decorated can only be DTL. In addition, silver Discussion grains were also observed over the PSE (Fig. 7b) . Thus osteoponHuman urine is always supersaturated in kidney stone mineral tin mRNA appears to be present at the same sites where constituents 2J. In particular, with regard to calcium oxalates and phosphates, the relative supersaturation ranges from several-fold to 30 to 50-fold. Urine, however, also is inhibitory for stone mineral crystal growth, apparently by virtue of its content of naturally occurring inhibitory factors.
These naturally occurring crystal growth inhibitors include physicochemical factors such as urinary concentration, pH and temperature, as well as inorganic and organic molecules [2] . Among the organic crystal growth inhibitors, macromolecules have attracted considerable recent interest. Nephrocalcin, an acidic glycoprotein shown to slow calcium oxalate crystal growth, has been isolated from urine, kidney tissue or both in several different vertebrate species including the rat [11] [12] [13] . Although immunoreactivity of the nephrocalcin has been demonstrated in proximal tubules and the thick ascending limbs in both human and mouse kidney [14] , further details of its cellular localization or processing have not been reported.
The other acidic glycoprotein that inhibits stone mineral crystal growth is uropontin, a urinary protein apparently identical to the bone matrix protein osteopontin [51. Osteopontin has been studied somewhat more extensively than nephrocalcin because it has been cloned and sequenced [15] [16] [17] [18] . Osteopontin is a constituent of normal bone matrix, but it is also found in the organic matrix of kidney stones [16, 19] . In addition, it is secreted into culture medium by several renal cell lines and into the urine by the normal intact kidney [1, 5, 20, 21] . Osteopontin message (mRNA) can be extracted from the kidney, indicating that this organ is a site of osteopontin synthesis [22] [23] [24] . However, investigations of the cellular and subcellular distribution of the protein within the kidney have yielded some conflicting results.
Nomura et al, using an RNA probe made from 2ar, identified osteopontin message in embryonic and newborn mouse kidney [24] . In situ hybridization was noted over tubules in the cortex and extended into the medulla. Presumably, the former are proximal tubules and the latter ioops of Henle. Collecting ducts in the cortex were positive in the embryos, but high power examination of the newborn cortex was not reported. In the medulla, collecting ducts were felt to be negative. A positive signal was also observed in the papillary surface but was felt to be an "edge-effect artifact." Mark et al reported immunostaining in dewaxed paraffin-embedded sections which had been immersion-fixed in paraformaldehyde-periodate-lysine fixative [25] . Electron microscopy was also performed in similarly fixed frozen sections which had been stained by the immunoperoxidase method prior to embedding. They used an antiserum raised in rabbit against the 44 kD bone matrix protein. Immunofluorescence was primarily observed in the outer stripe of the outer medulla. Sections stained for both osteopontin by immunoperoxidase and alkaline phosphatase by an azo-dye method showed colocalization. The ultrastructure showed staining product in large subapical vesicles and in "lysosome-like bodies" throughout the cell. They interpreted this localization to reflect endocytotic uptake of filtered protein. Reinholt et al, in studies reported in abstract form, used a polyclonal antibody against recombinant rat osteopontin to perform immunocytochemical staining in rat tissues [26] . Staining was observed in renal papillae which was especially intense on basolateral cell surfaces and less so on luminal cell surfaces, The reasons for the differences between the current study and those referred to above are not completely apparent. In some of the studies, kidneys were fixed by immersion rather than the perfusion fixation used in the current study. Depending upon the rapidity of fixation, osteopontin may have been degraded or may have diffused away from the sites of production. Unfixed frozen kidneys, for example, do not reveal an osteopontin signal (data not shown). Diffusion of osteopontin from DTL, in particular, and uptake into downstream sites during tissue preparation could be responsible for some of the reports of osteopontin immunostaining in thick ascending limb and more distal segments as observed in a number of the studies. Problems with tissue preservation may also account for some of the differences in localization of osteopontin mRNA. Ischemia, for example, appears to activate osteopontin expression and, presumably, message in a number of nephron segments 3O].
Although the antiserum used was raised against a protein isolated from the medium from cultured mouse cells, it is unlikely that it is recognizing something other than rat osteopontin. First, immunocytochemistry gave the same results with either unpurified or affinity-purified antibody. In addition, the probe used for in situ hybridization was transcribed from a cDNA for mouse osteopontin which codes for a protein that is 85% identical with the rat protein.
Immunogold electron microscopy demonstrated osteopontin in a population of vesicles in the apical portion of DTL and of the PSE. This result, together with the finding of significant osteopontin levels in rat urine by ELISA, suggest that this protein is being secreted into tubular fluid or urine by DTL cells and PSE cells, respectively. Given its property of inhibiting stone mineral crystal growth [1] , it may be significant that osteopontin appears to be produced and secreted at sites at or just proximal to where urine is likely to be most highly supersaturated in stone mineral constituents.
